| CASE REPORT |
|
| Year : 2015 | Volume
: 5
| Issue : 3 | Page : 113-116 |
|
|
Dapsone-induced hypersensitivity syndrome, hemolytic anemia, and severe agranulocytosis
Jemshad Alungal1, Mansoor C Abdulla1, Noorudheen Kaladi Kunnummal2, Amrutha Sivadasan1
1 Department of General Medicine, M.E.S. Medical College, Perinthalmanna, Kerala, India
2 Specialist, Geriatrics, Hamad Medical Corporation, Doha, Qatar
Correspondence Address:
Dr. Jemshad Alungal
Department of General Medicine, M.E.S. Medical College, Perinthalmanna - 679 338, Kerala
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-0738.158377
|
|
|
Dapsone is used for the treatment of leprosy and a variety of blistering skin diseases. It may cause severe adverse drug reaction(s) with multiorgan involvement. We report the case of a 48-year-old female who developed dapsone hypersensitivity syndrome (DHS), hemolytic anemia, and severe agranulocytosis with secondary cavitating pseudomonal pneumonia due to dapsone. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
